--- title: Northern Arizona Healthcare (NAH) Partners with InsightRX on the First Commercial Precision Dosing Model For Heparin description: InsightRX and Northern Arizona Healthcare (NAH) announce they will make precision dosing software for heparin available to pharmacists their site. image: https://blog.insight-rx.com/hubfs/AI-Generated%20Media/Images/inside%20of%20a%20hospital-1.jpeg --- [![InsightRX](https://blog.insight-rx.com/hubfs/insightrx_logo_white-teal.svg)](https://blog.insight-rx.com/) - For Providers - Solutions - [MIPD for Providers Explore our full solution for Bayesian model-informed dosing](https://www.insight-rx.com/mipd) - [Future of Pharmacy Learn what's next for AI in health tech, and why architecture matters](https://www.insight-rx.com/future) - Products - [InsightRX Nova Bayesian dosing (MIPD) app for bedside clinical decision support](https://www.insight-rx.com/provider/nova) - [InsightRX Apollo Real-time clinical analytics to measure outcomes](https://www.insight-rx.com/provider/apollo) - [Drug Modules Available medications for precision dosing apps](https://www.insight-rx.com/provider/drug-modules) - [For Life Sciences](https://www.insight-rx.com/life-sciences) - Overview - [InsightRX for Life Sciences Explore our solution for biopharma and clinical trial use](https://www.insight-rx.com/life-sciences) - Products - [Nova for Life Sciences Precision dosing app for clinical trial use](https://www.insight-rx.com/life-sciences/nova) - [Astra for Life Sciences AI-native environment for PK/PD modeling and simulation](https://www.insight-rx.com/life-sciences/astra) - Platform - [Continuous Learning Patented process for model retraining and improvement](https://www.insight-rx.com/platform/continuous-learning) - [Integrations Platform interoperability setup with EHRs, EDCs, and more](https://www.insight-rx.com/platform/integrations) - [Security & Regulatory Standards for product development and release](https://www.insight-rx.com/platform/security-regulatory) - [Success & Support Pharmacist-led training, onboarding, and education](https://www.insight-rx.com/platform/support) - Resources - Science - [Data Science Explore the science and learn more about our R&D](https://www.insight-rx.com/data-science) - [Scientific Publications Impactful research manuscripts with at least one InsightRX author](https://www.insight-rx.com/data-science/scientific-publications) - [How to Cite Using one of our apps? Follow this easy guide for citation in research](https://www.insight-rx.com/how-to-cite-insightrx-nova) - Explore - [Success Stories Case studies from real InsightRX customers about their journey](https://www.insight-rx.com/success-stories) - [White Papers In-depth analysis and best practices for review and download](https://blog.insight-rx.com/resources/tag/white-papers) - [Pubs. Using InsightRX Review research that has used InsightRX applications](https://www.insight-rx.com/publications-using-insightrx-software) - [Blog](https://blog.insight-rx.com/resources) - [All Blog Posts Read the latest posts by our team of experts](https://blog.insight-rx.com/resources) - [Product Innovation The latest updates on our products, services, and science](https://blog.insight-rx.com/resources?section=product_innovation) - [Thought Leadership Posts from our team of experts on PK, MIPD, science, and more](https://blog.insight-rx.com/resources?section=thought_leadership) - Company - About - [About Us Our story, what drives us and why we're passionate about our work](https://www.insight-rx.com/about) - [Leadership Founders and team leaders who strive toward excellence in MIPD](https://www.insight-rx.com/leadership) - [Advisory Board Scientists and experts to ensure our collective success](https://www.insight-rx.com/advisory-board) - [Careers Interested in joining? View available openings here](https://www.insight-rx.com/careers) - [Customers Hear what others have to say about their experience](https://www.insight-rx.com/customers) - Press - [All Stories InsightRX news, company updates, and more](https://blog.insight-rx.com/press-releases) - [Press Releases Announcements for events, partnerships, and company updates](https://blog.insight-rx.com/press-releases?section=press_releases) - [Media InsightRX in the news — digital, print, podcasts, and other outlets](https://blog.insight-rx.com/press-releases?section=media) [![Contact Us](https://no-cache.hubspot.com/cta/default/40041574/interactive-193831493462.png)](https://cta-service-cms2.hubspot.com/web-interactives/public/v1/track/redirect?encryptedPayload=AVxigLIVhNAV4frdGw7WK4%2FsUL9BSW7sTFfaUWeB6c0miW6Ak22RBUNE5R8BeaQrWqzDSork53FkrNEqiSn%2FTM4f%2BVzPNcA0Ikxp7y6GqZRUQJ2HulFNF849cXXSebQBDVQXFR3hVvn8tZ3jkxYoygqRgjFUwIOapgI0FM8UFCm2xhxz2SgLhEGqk1U%3D&webInteractiveContentId=193831493462&portalId=40041574) [![Contact Us](https://no-cache.hubspot.com/cta/default/40041574/interactive-193831493462.png)](https://cta-service-cms2.hubspot.com/web-interactives/public/v1/track/redirect?encryptedPayload=AVxigLIVhNAV4frdGw7WK4%2FsUL9BSW7sTFfaUWeB6c0miW6Ak22RBUNE5R8BeaQrWqzDSork53FkrNEqiSn%2FTM4f%2BVzPNcA0Ikxp7y6GqZRUQJ2HulFNF849cXXSebQBDVQXFR3hVvn8tZ3jkxYoygqRgjFUwIOapgI0FM8UFCm2xhxz2SgLhEGqk1U%3D&webInteractiveContentId=193831493462&portalId=40041574) Press Releases # Northern Arizona Healthcare (NAH) Partners with InsightRX on the First Commercial Precision Dosing Model For Heparin - Published June 13, 2024 By [InsightRX Communications](https://blog.insight-rx.com/press-releases/author/insightrx) ![](https://blog.insight-rx.com/hubfs/AI-Generated%20Media/Images/inside%20of%20a%20hospital-1.jpeg) SAN FRANCISCO & FLAGSTAFF, Ariz. June 13, 2024 - Today, InsightRX and Northern Arizona Healthcare (NAH) announced they will make InsightRX’s precision dosing software for heparin therapy available to NAH’s pharmacists at Flagstaff Medical Center.  NAH expects this deployment to decrease the time it takes to therapeutically dose hospitalized patients with unfractionated heparin to treat and prevent blood clots; improving patient outcomes. NAH is a multi-site, not-for-profit health system that views precision dosing as a transformative approach for advancing medical practice and recognizes [InsightRX’s continuous learning platform](https://www.insight-rx.com/platform/continuous-learning/) as the solution for clinicians to standardize high-quality care practices. > “InsightRX was developed to easily integrate into our daily Cerner workflows and individualize heparin therapy with the most advanced methods of patient safety monitoring,”said Dr. Scott Waldrop, System Director of Pharmacy, Northern Arizona Healthcare. InsightRX's integrated heparin dosing platform seamlessly imports patient data from NAH's electronic health records to create a graph of a patient's real-time coagulation status using their current blood draw. This allows clinicians to better identify patients with abnormal bleeding disorders or those at high risk for severe blood clots. Additionally, clinicians can simulate the impact of a recommended heparin dose before verifying the prescription. > “Anticoagulants have consistently been identified by our providers as a troubling cause of adverse drug events (ADEs) in the inpatient setting. Despite advances in therapeutic heparin dosing and monitoring, determining the right dose continues to be challenging because each patient eliminates heparin at their own rate, based on variables such as their size, blood composition, and underlying disease state,” said Dr. Jon Faldasz, Senior Director of Product and Customer Experience, InsightRX. | ![Heparin PR Img.001](https://blog.insight-rx.com/hs-fs/hubfs/Heparin%20PR%20Img.001.png?width=1552&height=1007&name=Heparin%20PR%20Img.001.png) | ![Heparin PR Img.002](https://blog.insight-rx.com/hs-fs/hubfs/Heparin%20PR%20Img.002.png?width=1527&height=1007&name=Heparin%20PR%20Img.002.png) | | --- | --- | | Faster anticoagulation attainment by the first measured activated partial thromboplastin time (aPTT) level | Sustained duration within a therapeutic anticoagulation range through the first week of therapy | Having used InsightRX’s flagship [infectious disease modules](https://info.insight-rx.com/provider/drug-modules/id-core) for over three years to review approximately 5,600 treatment courses of vancomycin, NAH now has the unique clinical advantage of being amongst the first to adopt a comprehensive anticoagulation stewardship program augmented with InsightRX for their growing health care system. This news continues to follow successful deployments of [InsightRX Nova](https://www.insight-rx.com/platform/insightrx-nova/) and [InsightRX Apollo](https://www.insight-rx.com/platform/insightrx-apollo/) at approximately 800 hospitals in the U.S., impacting over one million patients. In quarter one of this year, [CIBC Innovation Banking](https://blog.insight-rx.com/press-releases/cibc-innovation-banking-provides-growth-capital-to-insightrx) announced that it had provided growth financing to InsightRX which would allow them to enhance the development of new therapies to improve patient safety in the healthcare drug development and direct patient settings. This work will power enhancements to InsightRX’s core product lines and enable a new wave of possibilities with the integration of artificial intelligence (AI) in healthcare. [NAH recently announced plans](https://www.nahealth.com/about-us/expansion) to explore locations for a new hospital. The next phase for their Central Flagstaff Clinic in 2024 will include expanded cardiology services, primary care offices, and a new urgent care clinic. Additionally, they will begin remodeling and expanding an outpatient surgery center at the property formerly known as the Summit Center, which is tentatively planned to reopen in mid-2026. --- ## About Northern Arizona Healthcare [Northern Arizona Healthcare](https://www.nahealth.com/) (NAH) is a not-for-profit, people-centered healthcare system providing comprehensive care through two hospitals – Flagstaff Medical Center and Verde Valley Medical Center – which have a combined capacity of nearly 400 beds. Flagstaff Medical Center is the only Level 1 Trauma Center north of Phoenix, serving a region home to more than 750,000 people with a health system team of over 3,000 doctors, nurses, and other health care experts. Dedicated to improving health and healing, at NAH, better care reaches far beyond the hospital’s walls to affect communities where the need is greatest. [implementation](https://blog.insight-rx.com/press-releases/tag/implementation) [data science](https://blog.insight-rx.com/press-releases/tag/data-science) [heparin](https://blog.insight-rx.com/press-releases/tag/heparin) #### On this page… **Connect with us to get the latest blog updates, instantly sent to your inbox** ## Dig deeper. Explore related articles and additional posts on the InsightRX blog. [Press Releases Oct 28, 2025 The Christ Hospital Health Network Pharmacy Uses New Technology to Better Serve Patients](https://blog.insight-rx.com/press-releases/christ-hospital-pharmacy-technology-improves-patient-care) [Press Releases Apr 4, 2023 InsightRX Presents Research Evaluating Effectiveness of Model-Informed Precision Dosing for Heparin at Annual Anticoagulation Forum Meeting](https://blog.insight-rx.com/press-releases/insightrx-presents-research-evaluating-effectiveness-model-informed-precision-dosing-heparin-annual-anticoagulation-forum-meeting) [Press Releases Jul 8, 2020 Pharmacy and healthcare professionals nationwide recognize patient safety benefits of new consensus vancomycin dosing guidelines, but fewer than one in three plan to adopt them](https://blog.insight-rx.com/press-releases/pharmacy-healthcare-professionals-recognize-patient-safety-benefits-vancomycin-dosing-guidelines-plan-adopt) #### What We Do ##### For Providers - [Nova (Bayesian Dosing)](https://www.insight-rx.com/provider/nova) - [Apollo (Clinical Analytics)](https://www.insight-rx.com/provider/apollo) - [Drug Modules](https://www.insight-rx.com/provider/drug-modules) ##### For Life Sciences - [Nova (MIPD for Clinical Trials)](https://www.insight-rx.com/life-sciences/nova) - [Astra (AI-Powered Clin Pharm)](https://www.insight-rx.com/life-sciences/astra) - [Companion Applications](https://www.insight-rx.com/life-sciences/nova#companion-applications) #### How We Do It ##### Platform - [Continuous Learning](https://www.insight-rx.com/platform/continuous-learning) - [Integrations](https://www.insight-rx.com/platform/integrations) - [Security & Regulatory](https://www.insight-rx.com/platform/security-regulatory) - [Success & Support](https://www.insight-rx.com/platform/success-support) ##### Science - [Data Science](https://www.insight-rx.com/data-science) - [Scientific Publications](https://www.insight-rx.com/data-science/scientific-publications) #### Information ##### Resources - [Success Stories](https://www.insight-rx.com/success-stories) - [White Papers](https://www.insight-rx.com/white-papers) - [Publications Using InsightRX](https://www.insight-rx.com/publications-using-insightrx-software) - [How to Cite InsightRX](https://www.insight-rx.com/how-to-cite-insightrx-nova) ##### Blog - [All Posts](https://blog.insight-rx.com/resources) - [Product Innovation](https://blog.insight-rx.com/resources?section=product_innovation) - [Thought Leadership](https://blog.insight-rx.com/resources?section=thought_leadership) #### About - [Our Story](https://www.insight-rx.com/about) - [Leadership](https://www.insight-rx.com/leadership) - [Advisory Board](https://www.insight-rx.com/advisory-board) - [Our Customers](https://www.insight-rx.com/customers) - [Press Releases](https://blog.insight-rx.com/press-releases?section=press_releases) - [Media](https://blog.insight-rx.com/press-releases?section=media) - [Careers](https://www.insight-rx.com/careers) - [Contact](https://www.insight-rx.com/contact-us) --- ![CE marking](https://blog.insight-rx.com/hubfs/ce-mark-white.svg) InsightRX Nova is HITRUST CSF r2 certified, CE marked, and 21 CFR Part 11 compliant. Our quality management, risk management, software lifecycle, and usability engineering processes conform to ISO 13485, IEC 62304, ISO 14971, IEC 62366-1, and IEC 82304-1. InsightRX Nova is not considered to be a medical device in the U.S. and has not been submitted to the U.S. Food and Drug Administration for review or clearance. 740-05000-REC-01 · 08/2025 --- [![InsightRX](https://blog.insight-rx.com/hubfs/insightrx_logo_white-teal.svg)](https://www.insight-rx.com/) 548 Market Street #88083 San Francisco, CA 94104 --- © 2026 InsightRX, Inc. All rights reserved. [Privacy Policy](https://www.insight-rx.com/privacy-policy) Cookie Preferences ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "InsightRX Communications", "url" : "https://blog.insight-rx.com/press-releases/author/insightrx" }, "dateModified" : "2025-12-14T23:58:44.681Z", "datePublished" : "2024-06-13T13:41:00.000Z", "headline" : "Northern Arizona Healthcare (NAH) Partners with InsightRX on the First Commercial Precision Dosing Model For Heparin", "image" : [ "https://blog.insight-rx.com/hubfs/AI-Generated%20Media/Images/inside%20of%20a%20hospital-1.jpeg" ], "mainEntityOfPage" : { "@id" : "https://blog.insight-rx.com/press-releases/northern-arizona-healthcare-insightrx-precision-dosing-model-heparin", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.insight-rx.com/hubfs/insightrx_logo_color%20500%20x%20250-1.png" }, "name" : "InsightRX" } } ```